Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	21073
Country	United States

Received	2015-06-29 18:50
Peer-Review Started	2015-07-11 08:57
To Make the First Decision	2015-10-08 15:54
Return for Revision	2015-10-13 17:33
Revised	2015-10-29 21:10
Second Decision	2015-12-24 17:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-01-07 16:23
Articles in Press	2016-01-07 16:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-01-23 20:19
Publish the Manuscript Online	2016-01-31 19:20

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Implications of multigene testing for hereditary breast cancer in primary care
Manuscript Source	Invited Manuscript
All Author List	Meghna S Trivedi and Katherine D Crew
Funding Agency and Grant Number
Corresponding Author	Katherine D Crew, MD, MS, Assistant Professor of Medicine and Epidemiology, Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Ave, 10-1072, New York, NY 10032, United States. kd59@cumc.columbia.edu
Key Words	Genetic testing; BRCA1; BRCA2; Heredi­tary breast cancer; Multigene testing
Core Tip	Multigene testing for hereditary breast cancer is readily available and some panels can identify over 100 gene mutations. Risk-reducing strategies are avai-lable for women with mutations in high-penetrance genes, whereas strategies for managing women with mutations in low-moderate penetrance genes is less clear. Appropriately identifying women who should undergo genetic counseling for hereditary breast cancer and implementing recommended guidelines in those who are found to be high risk can reduce the incidence and mortality of breast cancer.
Publish Date	2016-01-31 19:20
Citation	Trivedi MS, Crew KD. Implications of multigene testing for hereditary breast cancer in primary care. World J Obstet Gynecol 2016; 5(1): 50-57
URL	http://www.wjgnet.com/2218-6220/full/v5/i1/50.htm
DOI	http://dx.doi.org/10.5317/wjog.v5.i1.50

Full Article (PDF)	WJOG-5-50.pdf
Full Article (Word)	WJOG-5-50.doc
Manuscript File	21073-Review.docx
Answering Reviewers	21073-Answering reviewers.pdf
Audio Core Tip	21073-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21073-Conflict-of-interest statement.pdf
Copyright License Agreement	21073-Copyright assignment.pdf
Peer-review Report	21073-Peer-review(s).pdf
Scientific Misconduct Check	21073-Scientific misconduct check.pdf
Scientific Editor Work List	21073-Scientific editor work list.pdf